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ABSTRACT: The glycosome of the pathogenic African
trypanosome Trypanosoma brucei is a specialized peroxisome
that contains most of the enzymes of glycolysis and several
other metabolic and catabolic pathways. The contents and
transporters of this membrane-bounded organelle are of
considerable interest as potential drug targets. Here we use
epitope tagging, magnetic bead enrichment, and SILAC
quantitative proteomics to determine a high-conﬁdence
glycosome proteome for the procyclic life cycle stage of the
parasite using isotope ratios to discriminate glycosomal from
mitochondrial and other contaminating proteins. The data
conﬁrm the presence of several previously demonstrated and
suggested pathways in the organelle and identify previously
unanticipated activities, such as protein phosphatases. The implications of the ﬁndings are discussed.
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■ INTRODUCTION
Eukaryotic cells possess membrane-bound organelles called
peroxisomes, deﬁned by the presence of the Pex proteins
responsible for their biogenesis. Peroxisomes generally contain
enzymes to deal with reactive oxygen species and enzymes of
fatty acid β-oxidation.1 Beyond these common functions,
peroxisome content and function vary between species. The
peroxisomes of the trypanosomatids are called glycosomes
because, uniquely, they contain most of the enzymes of
glycolysis.2,3 Ether lipid and isoprenoid/sterol biosynthesis are
relatively common peroxisomal functions, and these too have
been demonstrated and suggested, respectively, to be present in
trypanosomatids.4,5 Other metabolic processes that are atypi-
cally compartmentalized in glycosomes include purine salvage,
the latter stages of pyrimidine biosynthesis,6,7 and much of
sugar nucleotide biosynthesis.8−14
An inventory of an organelle’s contents is highly desirable to
help understand its functional signiﬁcance, its mechanism(s) of
biogenesis, and its metabolite transport systems. Given the
parasitic nature of the trypanosomatids and the serious human
and animal diseases inﬂicted by them, glycosome metabolism
and organization are of considerable interest with respect to
identifying therapeutic opportunities related to their unusual
metabolic compartmentalization and requisite metabolite
transport.15,16
Here we describe the glycosome proteome of the procyclic
form of Trypanosoma brucei. This organism causes human
African trypanosomiasis (African sleeping sickness) and nagana
in cattle and is transmitted by the tsetse ﬂy in much of sub-
Saharan Africa. The procyclic form of the parasite normally
resides in the gut of the tsetse ﬂy vector and is the life cycle
stage most readily grown to moderate densities in cell culture.
Given that subcellular fractionation can only provide an
enrichment of a given organelle, the principle problem in
obtaining high-conﬁdence organelle proteomes is in deciding
which of the many hundreds or thousands of protein “hits” are
genuine components of the organelle rather than contaminants
from other locations. We therefore decided to approach this
problem for the trypanosome glycosomes by using epitope-
tagged glycosomes and stable isotope labeling in cell culture
(SILAC), such that in antiepitope pull-out experiments we can
distinguish genuine glycosomal components from contaminants
according to peptide isotopic signatures. The general approach
is summarized in Figure 1, and we compare our results to
previously published glycosome proteomes.17−19
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■ EXPERIMENTAL PROCEDURES
Cell Culture and Transfection of Procyclic Form T. brucei
Cells
Procyclic form T. brucei 427 strain containing T7 RNA
polymerase and Tet repressor protein, respectively, under
control of G418 and hygromycin (clone 29.13.6 cells, kindly
provided by George Cross and referred to from hereon as wild-
type cells)20 were grown at 28 °C without CO2 in original
SDM-79 medium,21 containing 15% (v/v) heat inactivated fetal
bovine serum (FBS), 2 g/L sodium bicarbonate, 2 mM
glutamax I (Invitrogen), 22.5 μg/mL hemin (added from a 10
mg/mL stock in 50 mM NaOH), and pH adjusted to 7.3.
Hygromycin B (Roche) at 50 μg/mL and G418 (Invitrogen) at
15 μg/mL were also added. These cells were electroporated
with 10 μg/cuvette of Not I linearized plasmid pGC1
containing an ORF encoding the full length T. brucei Pex13.1
protein sequence (Tb927.10.14720) fused to an N-terminal
green ﬂuorescent protein (eGFP) tag, a kind gift from Paul
Michels.22 Electroporation conditions were as previously
described,23 and selection was done using 10 μg/mL of
blasticidin (Invitrogen). The resistant cells were cloned by
dilution to a single cell/mL in 96-well plates using SDM-79
containing all reagents previously described but with 20% (v/v)
heat-inactivated FBS and 4 g/L sodium bicarbonate and grown
in a CO2 incubator at 28 °C. Thirty clones were selected and
activated with tetracycline added from a freshly prepared 1 mg/
mL stock in 70% ethanol. Clones were tested by Western blot
and by ﬂuorescence microscopy to conﬁrm the appropriate
GFP-tagging of Pex13.1 and its glycosomal localization.
SILAC Labeling of T. brucei Procyclic Form Cells
The SILAC labeling of T. brucei procyclic form cells was
performed as described recently.24 In brief, log phase parasites
were washed three times with 10 mL of SDM-79 depleted of L-
lysine and L-arginine (SDM-79-RK) and used to seed cultures
where the SDM-79-RK medium was supplemented with either
normal isotopic abundance L-arginine and L-lysine (SDM-79 +
R0K0, referred to as light label) or with [U−13C]-L-Arginine·
HCl and [4,4,5,5-2H]-L-lysine·2HCl (SDM-79 + R6K4, referred
to as heavy label). The stable isotope-labeled amino acids were
obtained from Cambridge Isotope Laboratories, U.K. The
heavy and light labels were used at the same concentration, as
described in the original SDM-79 formulation.21 In general,
apart from the label-swap (Table 1, experiment 4), wild-type
cells were suspended at 2.5 × 106 cells/mL in SDM-79 + R0K0,
and GFP-Pex13.1 expressing cells were suspended in SDM-79
+ R6K4 at the same concentration. Cultures were diluted about
7.7-fold (back to ∼2.5 × 106 cells/mL) every 2 days with fresh
media to allow for eight cell divisions under the labeling
conditions and to enlarge cultures to about 500 mL at ﬁnal
concentration of ∼2.5 × 107 cells/mL. The expression of GFP-
Pex13.1 was induced by adding 40 ng/mL fresh tetracycline 16
h prior to harvesting. Cells were counted, and R0K0- and
R6K4-labeled cells were mixed 1:1, lysed, immunoprecipitated
using anti-GFP magnetic beads, eluted, and processed for
proteomics, as described later.
The SILAC label-chase experiment was performed similarly,
except that after steady-state labeling for eight cell divisions
both cultures were split in half. One half of each culture was
washed twice with, and resuspended in, R0K0 media to perform
a chase for 5 h at 28 °C, while the other halves of the steady-
state labeled cultures were simply harvested at the end of the
labeling period and processed as described later.
Cell Lysis, Subcellular Fractionation, and Glycosome
Enrichment
Light and heavy amino-acid-labeled cells were harvested
separately by centrifugation at 600g for 10 min at 4 °C,
washed twice, and resuspended in 250 mM sucrose, 25 mM
Tris-HCl pH 7.4, and 1 mM EDTA (STE buﬀer), counted
using a Casy Innovatis Counter (Scharfe), and mixed 1:1 to
obtain a ﬁnal cell suspension of 2 × 109 cells/mL in STE
containing 0.1 mM 1-chloro-3-tosylamido-7-amino-2-heptone
(TLCK), 1 μg/mL leupeptin, 1 μg/mL aprotinin, and complete
protease inhibitor cocktail without EDTA (Roche). The
combined cells were lysed with 2 shots of 10 000 psi using a
One Shot (Constant Cell Disruption System; Northants, U.K.).
Figure 1. Overview of the approach taken to obtain a high-conﬁdence
glycosome proteome. Wild-type procyclic form trypanosomes were
grown in normal (R0K0, light) medium, and cells transfected to
express GFP-tagged Pex13.1 were labeled with heavy (R6K4) Lys and
Arg. The cells were mixed 1:1, and glycosomes were enriched by
centrifugation, followed by aﬃnity-selection on anti-GFP magnetic
beads. Peptides from genuine glycosome components have high
heavy/light isotope ratios, whereas those from contaminants have
isotope ratios close to 1:1.
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These conditions of cell density and pressure had previously
been optimized to give the best yield of glycosomes through a
conventional density centrifugation procedure.25 The lysates
were centrifuged twice at 2000g for 15 min at 4 °C to remove
any remaining live cells, cell ghosts. and nuclei. The supernatant
was then centrifuged twice at 5000g for 15 min to remove
material enriched in mitochondria, known as large granular
fraction. (Note: Further subcellular fractionation, by pelleting
the small granular fraction, resuspending, and performing
density gradient centrifugation,25 was avoided because previous
experiments had shown that anti-GFP immuno-aﬃnity enrich-
ment of the tagged Pex13.1-GFP glycosomes was compromised
when this was performed, possibly due to glycosome
aggregation or membrane fusion during the high-speed
pelleting step.) The supernatant from the 5000g spin, enriched
in glycosomes and endoplasmic reticulum (ER) and containing
cytosol, was precleared by rotating with 0.2 mL of magnetic
beads without antibody for 1 h at 4 °C. The preclearing beads
were removed on a magnet, and the supernatant was
immunoprecipitated using magnetic beads coupled to anti-
GFP, as described in Table 1, using either 16 μg of
immunopure anti-GFP mouse monoclonal antibody (Roche)
and 0.2 mL magnetic protein G dynabeads at 30 mg/mL
(Invitrogen) for 1 h at 4 °C or camelid anti-GFP (Chromoteck,
Germany) precoupled to NHS-magnetic beads according to the
manufacturers instructions (Pierce, Thermo Scientiﬁc) for 1 h
at 4 °C. Beads were washed three times with 1 mL of STE then
once with Tris-buﬀered saline (TBS) and resuspended in 35 μL
of TBS.
Sample Preparation for Proteomics
Samples for analysis by mass spectrometry were prepared either
by SDS-PAGE separation followed by in-gel trypsin digestion
or by FASP followed by strong cation exchange (SCX)
chromatography. For SDS-PAGE, an equal volume of 2× SDS-
sample buﬀer and 0.1 M fresh dithiothreitol (Cleland’s reagent,
Ultrol grade, Calbiochem) was added and heated to 50 °C for
20 min. Samples were run in 10% Nupage gels with MOPS
running buﬀer and stained with Simply Blue (Invitrogen). Gel
lanes were cut in slices, as shown in Figure S1 in the Supporting
Information, and washed sequentially in 50% (v/v) acetonitrile,
0.1 M NH4HCO3, 0.1 M NH4HCO3/acetonitrile (1:1 v/v),
and acetonitrile. Gel pieces were dried in Speed-vac (Thermo
Scientiﬁc) in-gel reduced with 0.01 M dithiothreitol, alkylated
with 0.05 M iodoacetamide (Sigma) for 30 min in dark, washed
in 0.1 M NH4HCO3, and digested with 12.5 μg/mL modiﬁed
sequence grade trypsin (Roche) in 0.02 M NH4HCO3 for 16 h
at 30 °C. Tryptic peptides were recovered in 50% acetonitrile
and 2.5% formic acid and lyophilized prior to analysis by LC−
MS/MS.
For ﬁlter-aided sample preparation (FASP),26 an equal
volume of 4% SDS in 0.1 M Tris-HCl pH 7.2 containing 0.1 M
dithiothreitol was added, and FASP protocol II was followed
but using 10 000 MWCO Vivacon 500 ﬁlters (Sartorius).
Tryptic peptides obtained from FASP were desalted using C18
Empore cartridges (Agilent Technologies) and freeze-dried.
Prior to SCX fractionation, samples were dissolved in 200 μL of
SCX solvent A (10 mM KH2PO4 pH 3.0, 30% acetonitrile) and
chromatographed as previously described.24 Fractions were
combined in 10 pools according to their UV absorbance at 210
nm and desalted using C18 microspin silica columns (Nest
group, USA), freeze-dried, and submitted to mass spectrometry.
Mass Spectrometry Data Acquisition and Processing
Liquid chromatography tandem mass spectrometry was
performed by the FingerPrints Proteomics Facility at the
University of Dundee.
For experiments 1 and 2, liquid chromatography was
performed on a fully automated Ultimate U3000 Nano LC
System (Dionex) ﬁtted with a 300 μm id × 5 mm Acclaim
PepMap 100 C18 trap column and a 75 μm × 15 cm Acclaim
PepMap C18 nanocolumn (Thermo Scientiﬁc). Samples were
loaded in 0.1% formic acid (buﬀer A) and separated using a
binary gradient consisting of buﬀer A and buﬀer B (90%
acetonitrile, 0.08% formic acid). Peptides were eluted with a
linear gradient from 2 to 35% buﬀer B over 65 min. For
experiments 3 and 4, liquid chromatography was performed on
a fully automated Ultimate 3000 RSLCnano system (Thermo
Scientiﬁc) ﬁtted with a 100 μm × 2 cm Acclaim PepMap100
trap column (5 μm particle size) and a 75 μm × 50 cm
PepMapRSLC C18 nanocolumn (2 μm particle size) (Thermo
Scientiﬁc). Samples were loaded in 0.1% formic acid (buﬀer A)
and separated using a binary gradient consisting of buﬀer A and
buﬀer B (80% MeCN, 0.08% formic acid). Peptides were eluted
with a linear gradient from 2 to 40% buﬀer B over 125 min and
a column temperature of 50 °C.
The HPLC systems were coupled to an LTQ Orbitrap Velos
Pro mass spectrometer (Thermo Scientiﬁc) equipped with a
Proxeon Easy-Spray nanosource. The mass spectrometer was
operated in data-dependent mode to perform a survey scan
Table 1. Summary of Individual SILAC Experiments Performed
biological
replicate exptsa
wild-type
cell labelb
GFP-Pex13.1
transgenic cell line
labelb preclearing beads used IP beads used
no. of fractions
prepared
by FASP and
SCX
(no. of LC−
MS/MS runs)c
no. of fractions
prepared
by SDS-PAGE
(no. of LC−
MS/MS runs)c
expt 1 R0K0 R6K4 protein G dynabeads mouse anti-GFP + protein G
dynabeads
0(0) 9(27)
expt 2 R0K0 R6K4 ethanolamine-inactivated Pierce
NHS-magnetic beads
camelid anti-GFP coupled to
NHS-magnetic beads
0(0) 8(24)
expt 3 R0K0 R6K4 ethanolamine-inactivated Pierce
NHS-magnetic beads
camelid anti-GFP coupled to
NHS-magnetic beads
10(30) 0(0)
expt 4 R6K4 R0K0 ethanolamine-inactivated Pierce
NHS-magnetic beads
camelid anti-GFP coupled to
NHS-magnetic beads
10(30) 0(0)
aBiological replicate 4 was a label-swap experiment, performed in parallel with replicate 3. bTrypanosome procyclic forms were labeled with
unlabeled L-Arg and L-Lys, designated as R0K0 or with [13C6 ]-L-Arg and [
2H4]-L-Lys, designated as R6K4.
cTryptic peptides were generated either
by trypsin in-gel digestion of protein bands from SDS-PAGE or by ﬁlter aided sample preparation (FASP) and further fractionation using strong
cation exchange chromatography (SCX).
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over a range of m/z 335−1800 in the Orbitrap analyzer
(resolution = 60 000), with each MS scan triggering 15 MS2
acquisitions of the 15 most intense ions. The Orbitrap mass
analyzer was internally calibrated on the ﬂy using the lock mass
of polydimethylcyclosiloxane at m/z 445.120024.
Data were processed using MaxQuant version 1.3.0.5,27
which incorporates the Andromeda search engine.28 Proteins
were identiﬁed by searching a protein sequence database
containing T. brucei brucei 927 annotated proteins (version 4
downloaded from TriTrypDB,28 http://www.tritrypdb.org/)
supplemented with the VSG221 sequence and those of
frequently observed contaminants (porcine trypsin, bovine
serum albumin, and human keratins). Search parameters
speciﬁed an MS tolerance of 10 ppm, an MS/MS tolerance
at 0.6 Da, and full trypsin speciﬁcity, allowing for up to two
missed cleavages. Carbamidomethylation of cysteine was set as
a ﬁxed modiﬁcation and oxidation of methionines, N-terminal
protein acetylation, and N-pyroglutamate were allowed as
variable modiﬁcations. Peptides were required to be at least six
amino acids in length, with a MaxQuant score >5 and false
discovery rates (FDRs) of 0.01 calculated at the levels of
peptides, proteins, and modiﬁcation sites based on the number
of hits against the reversed sequence database. SILAC ratios
were calculated using only peptides that could be uniquely
mapped to a given protein group and required a minimum of 2
SILAC pairs. The distribution of SILAC was normalized within
MaxQuant at the peptide level so that the median of log2 ratio
is zero to account for any errors in cell counting.27
Prior to statistical analysis, the outputs from MaxQuant were
ﬁltered to remove known contaminants and reverse sequences.
Quantitation of the fold-enrichment of glycosomal proteins by
GFP-Pex13.1 pull down versus the untagged control is derived
from four SILAC-labeled biological replicates, including one
label swap experiment. Replicate trimming was applied by
calculating the mean and standard deviation (σ) of the
distribution of the log2(H/L × L/H)
30 and discarding data
>2σ from the mean. Where SILAC ratios were reported in only
one experiment, they were discarded if the percentage variation
in the calculated SILAC ratio (calculated by MaxQuant) was
>100%.30 Because the Log2(H/L) ratios were not normally
distributed, with a distribution of high Log2(H/L) ratios
(glycosomal proteins) superimposed onto the normal distribu-
tion (nonspeciﬁc proteins) centered about zero, an intensity-
weighted local standard deviation30 of the normally distributed
background (Log2 H/L < |1.2|) was calculated. Data were
visualized using Perseus 1.3.0.4 (www.perseus-framework.org),
and further information on the identiﬁed proteins was obtained
from TriTrypDB (http://www.tritrypdb.org).28 Transmem-
brane domain prediction for protein hits was performed using
THMM analysis,34 and we searched for PTS1 and PTS2
(peroxisome targeting sequences) using the following motif
searches: [STAGCN][RKH][LIVMAFY]$ and ̂M.{0,20}[RK]-
[LVI].....[HQ][ILAF], respectively, in the TriTrypDB T. brucei
strain 927 predicted protein database.5
SDS-PAGE and Western Blotting
Proteins separated by SDS-PAGE (Nupage, Invitrogen) were
transferred onto nitrocellulose using iBlot system (Invitrogen).
After 7 min transfer in program 3, the nitrocellulose was
recovered and set up on a SNAPid system (Millipore) to
develop with antibodies, as recommended by manufacturer.
The blocking buﬀer used was 50 mM Tris-HCl pH 7.4, 0.15 M
NaCl, 0.25% BSA, 0.05% (w/v) Tween-20, 0.05% NaN3, and
2% (w/v) ﬁsh skin gelatin, ﬁltered (0.2 μm) to remove
particles. Mouse antiphosphomannose isomerase (PMI) serum
was raised against recombinant T. brucei PMI,14 and rabbit
antialdolase serum was a generous gift from Paul Michels.
These sera were diluted 1:1000 and 1:4000, respectively, in
blocking buﬀer. Puriﬁed mouse anti-GFP monoclonal antibody
(Roche) was diluted to 0.4 μg/mL in blocking buﬀer.
Secondary antibodies for the Licor Odyssey Imager were
diluted in blocking buﬀer containing 0.01% SDS (w/v) at 1:15
000 for infrared green antimouse (IRdye 800) and 1:20 000 for
infrared red (IRdye 680) antirabbit.
Light and Electron Microscopy
GFP-Pex13.1 mutant procyclic cells grown in SDM-79 were
incubated with and without 40 ng/mL tetracycline for 16 h and
pelleted by centrifugation at 600g for 10 min. Cells were
washed in phosphate-buﬀered saline (PBS), ﬁxed in 4% (w/v)
paraformaldehyde in PBS at 4 °C for 30 min, and placed on a
coverslip. After air-drying, coverslips were washed in PBS and
mounted onto slides using Prolong Gold with DAPI
(Invitrogen). GFP ﬂuorescence images were collected in a
Zeiss LSM 710 META confocal microscope, setting the red
channel for cell autoﬂuorescence.
Electron microscopy was performed on immunopuriﬁed
GFP-tagged glycosomes still attached to protein G dynabeads
after ﬁxation in 4% paraformaldehyde, 0.25% glutaraldehyde in
PBS overnight at 4 °C. For scanning electron microscopy
(SEM), immunopuriﬁed GFP-tagged glycosome beads were
retained on Track-Etch membrane ﬁlters (Nuclepore, What-
man) and processed as previously described,32 except that 8 nm
gold−palladium coating was used. For immune-transmission
electron microscopy (TEM), beads containing immunopuriﬁed
GFP-tagged glycosomes were ﬁxed as previously described and
blocked overnight in 10% normal goat serum and 1% (w/v)
ﬁsh skin gelatin (Sigma) in Tris buﬀered saline. The beads were
washed in blocking buﬀer and incubated for 1 h at room
temperature with 1:200 rabbit anti-Peroxin 11 (a kind gift from
Christine Clayton) in blocking buﬀer, washed, and developed
for 1 h at room temperature with 1:500 protein A conjugated to
10 nm gold (BBI Solutions). The beads were collected using a
magnet and resuspended in 1% aqueous osmium tetroxide,
dehydrated, and set in Durcupan epoxy resin (Sigma). Sections
were cut using a Leica Ultracut UCT system and analyzed using
a Philips Tecnai 12 TEM instrument. Regular TEM was
processed as described, but antibody steps were omitted.
■ RESULTS
Generation of Transgenic Procyclic form T. brucei
Expressing GFP-Pex13.1-Tagged Glycosomes
The wild-type procyclic cell line was genetically manipulated to
introduce a tetracycline-inducible ectopic copy of a gene
encoding the Pex13.1 protein with a GFP tag fused to its N-
terminus (GFP-Pex13.1). Because Pex13.1 is a transmembrane
protein that spans the glycosome membrane twice, with both
the N- and C-terminus on the surface of the glycosome (Figure
1),22 anti-GFP magnetic beads can be used to capture and
enrich whole glycosomes made by transgenic parasites
expressing the GFP-Pex13.1 construct. The inducible GFP-
Pex13.1-transformed cells were cloned by limiting dilution, and
the resulting 30 clones were induced with a range of
tetracycline concentrations. Cell lysates were analyzed by
Western blot for the presence of the GFP-Pex13.1 fusion
protein and by ﬂuorescence microscopy for the presence of
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GFP ﬂuorescent glycosomes. We observed that full induction
with 0.5 μg/mL tetracycline lead to unstable expression of
GFP-Pex13.1, such that following a burst of GFP-Pex13.1
expression the cells became unresponsive to tetracycline. This
may indicate that overexpression of GFP-Pex13.1 is detrimental
to trypanosomes. However, we were able to select a clone that,
when induced with 0.04 μg/mL tetracycline for 16 h, showed
reproducible and stable expression of the GFP-Pex13.1 fusion
protein (Figure 2A). This clone was analyzed by ﬂuorescence
microscopy and showed the presence of GFP tagged
glycosomes in the presence but not the absence of 0.04 μg/
mL tetracycline induction for 16 h (Figure 2B). Under these
induction conditions, the growth of this GFP-Pex13.1
expressing clone is very similar to the parental cell line (Figure
2C), allowing us to grow the transgenic and parental cell lines
in parallel for SILAC labeling.
To get a visual impression of our ability to enrich GFP-
Pex13.1-tagged glycosomes from trypanosome lysates with anti-
GFP magnetic bead preparations, we performed electron
microscopy on the sample obtained using mouse anti-GFP
and protein-G dynabeads. TEM showed the beads associated
with round organelle structures with dimensions consistent
with those of glycosomes (Figure 3A) that could be decorated
with rabbit anti-Pex11 antibody to a glycosome membrane
peroxin33 and detected with 10 nm gold-conjugated protein A
(Figure 3B). In addition, SEM of the beads showed several such
organelles associated with each magnetic bead (Figure 3C)
compared with control beads that had not been incubated with
trypanosome lysate (Figure 3D).
SILAC Labeling, GFP-Pex13.1-Tagged Glycosome
Enrichment, and Sample Processing
Four separate biological replicate SILAC experiments were
performed in total, and these are summarized in Table 1.
For three of these experiments, wild-type and transgenic
parasites expressing GFP-Pex13.1 were grown for eight cell
divisions in parallel and under identical conditions, except that
the transgenic parasites expressing GFP-Pex13.1 were grown in
“heavy medium” containing stable isotope-labeled Lys and Arg
(R6K4), whereas the wild-type cells were grown in “light
medium” containing unlabeled Lys and Arg (R0K0). In each
experiment, the transgenic parasites expressing GFP-Pex13.1
and the wild-type cells were harvested, washed, counted, mixed
together in a 1:1 ratio, and lysed. These lysates, containing
equal amounts of labeled and unlabeled proteins, were used to
capture the heavy-labeled GFP-Pex13.1 tagged glycosomes on
anti-GFP magnetic beads for proteomic analysis. Using this
protocol, speciﬁcally enriched glycosomal proteins can be
distinguished from nonspeciﬁc contaminant (nonglycosomal)
proteins by the isotope ratios of their tryptic peptides. Thus,
true glycosomal protein peptides will have high heavy/light
isotope ratios, whereas contaminant proteins will have heavy/
light isotope ratios close to 1.
For these three experiments, the beads were recovered
magnetically and washed prior to either (i) processing by SDS-
PAGE into gel-slices (see Figure S1 in the Supporting
Information) and performing in-gel reduction, S-alkylation,
and tryptic digestion for LC−MS/MS (Table 1, experiments 1
and 2) or (ii) boiling in SDS containing buﬀer and performing
Figure 2. Expression of GFP-Pex13.1 in procyclic form T. brucei. (A)
Cell lysate from 1.2 × 108 GFP-Pex13.1 transgenic parasites induced
with 40 ng/mL tetracycline for 16 h was immunoprecipitated with
GFP-trap magnetic beads, and the proteins eluted with boiling SDS-
sample buﬀer were separated by SDS-PAGE and subjected to Western
blotting with a mouse anti-GFP antibody, revealing the transgene
product. The positions of Ponceau red-stained molecular weight
markers are shown on the left. (B) Fluorescence imaging of the same
cells for GFP (green) and DNA (blue). (C) Growth curves of wild
type (open squares) and the GFP-Pex13.1 clone induced with 40 ng/
mL tetracycline (open circles). The wild-type and GFP-Pex13.1
expressing cells were grown in SDM-79+R0K0 and SDM-79+R6K4
media, respectively. Cells were passaged every 2 days, and the
cumulative growth is plotted against time.
Figure 3. Transmission and scanning electron microscopy of puriﬁed
GFP-tagged glycosomes attached to magnetic beads. (A) Transmission
electron micrograph showing a magnetic bead (left) attached to a
spherical organelle (glycosome). (B) Transmission immunoelectron
micrograph of a magnetic bead (bottom left) and attached GFP-tagged
glycosome labeled with rabbit anti-Pex11 antibody and antirabbit
antibody conjugated to 10 nm gold (arrow). (C) Scanning electron
micrograph of magnetic beads with attached GFP-tagged glycosomes.
(D) Scanning electron micrograph of a magnetic bead prior to the
capture of GFP-tagged glycosomes. The scale bars correspond to 0.1
μm in panels A and B and 1 μm in panels C and D.
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the FASP method,26 with subsequent fractionation into
subfractions by SCX HPLC prior to LC−MS/MS (Table 1,
experiment 3).
The fourth experiment was a so-called “label-swap”, whereby
the transgenic parasites expressing GFP-Pex13.1 were grown in
light medium, and the wild-type cells were grown in the heavy
medium. Otherwise, this experiment (Table 1, experiment 4)
was identical to that described in Table 1, experiment 3.
For all four experiments, the peptide fractions were run in
triplicate by LC−MS/MS (technical replicates). In total, data
from 111 LC−MS/MS runs were used for data analysis.
Proteomic Data Analysis
The data from each individual experiment (Table 1, experi-
ments 1−4) and the combined data for all four experiments
were used to search a T. brucei predicted protein database29
using MaxQuant software.27 For the proteins identiﬁed in the
combined data set, we performed a pairwise comparisons of the
log2(H/L) ratios with those for the proteins identiﬁed in the
four individual data sets. These showed good correlations
(Pearson coeﬃcients of 0.916, 0.872, 0.906, and 0.879; Figure
S2 in the Supporting Information). Consequently, we used the
combined data (after inverting the H/L ratios for experiment 4,
the label swap) for all further analyses. A total of 3182 proteins
were identiﬁed, at a false discovery rate of 1%, using the
combined data (Table S1 in the Supporting Information).
Each protein identiﬁcation was displayed on a plot (Figure 4)
of the Log10 value of the combined intensities of the unique
peptides of that protein (y axis) and the Log2 value of the mean
heavy to light isotope ratios of the same peptides (x axis).
Because of the signiﬁcant number of glycosomal proteins
selectively enriched by the anti-GFP bead pull-out procedure,
the Log2-transformed H/L ratios were not normally distributed
around zero. Essentially, there is a set of high Log2(H/L) ratio
glycosomal proteins superimposed onto a normal distribution
of nonspeciﬁc, contaminant, proteins with Log2(H/L) ratios
centered about zero, that is, Log2(H/L) < |1.2|. We used the
intensity-weighted local standard deviation of the normally
distributed contaminant proteins (Log2(H/L) < |1.2|) to
account for the fact that the H/L ratio of more intense ions
can be measured with greater certainty.30 We have then used
the calculated local standard deviation (sd) to divide the
proteins into three populations (Table S2 in the Supporting
Information). Group (i): A large group of 2876 proteins
centered around a Log2(H/L) ratio of 0, corresponding to
proteins that were not enriched by the anti-GFP pull-out, that
is, contaminant proteins. Group (ii): A group of 177 proteins
that are signiﬁcantly enriched in Log2(H/L) ratio over the ﬁrst
group by >3 sd and <8 sd. Group (iii): A group of 129 proteins
that are very highly enriched in Log2(H/L) ratio over the ﬁrst
group by >8 sd
Group (iii) Proteins Form the Core of a High-Conﬁdence
Glycosome Proteome
The 129 highly enriched group (iii) proteins include 9
members of the Pex proteins, involved in glycosome biogenesis,
and 74 enzyme or enzyme-complex proteins, covering 65
diﬀerent enzyme activities. The latter (Table S3 in the
Supporting Information) include the seven glycolytic enzymes
from hexokinase (HK) to phosphoglycerate kinase (PGK) as
well as the NAD-dependent glycerol-3-phosphate dehydrogen-
ase (G3PDH) and glycerol kinase (GK). The presence of the
Pex and glycolytic pathway components conﬁrms that this
group of proteins includes the contents of mature glycosomes.
This is further supported by the presence of all of the enzymes
of purine salvage and pyrimidine biosynthesis, with the
exceptions of bifunctional orotate phosphoribosyltransferase/
orotidine 5′-phosphate decarboxylase (OPRT/OPDC) and
phosphoribosyl pyrophosphate synthase (PRPS), although the
latter appears in the group (ii) proteins. Also consistent with
known glycosome biochemistry is the presence of many
components of the peroxide and superoxide inactivation
system, that is, trypanothione reductase (TR), tryparedoxins
(TPN), tryparedoxin peroxidase (TPX), and isocitrate
dehydrogenase (ICDH), which provides the NADPH necessary
to provide the reducing power for the system. In addition, L-
galactonolactone/D-arabinolactone oxidase (GLO), involved in
the synthesis of the antioxidant ascorbate, was found, consistent
with its reported glycosomal location.35 Most peroxisomes are
synonymous with long-chain fatty acid beta-oxidation, and,
appropriately, the trifunctional enoyl-CoA hydratase/enoyl-
CoA isomerase/hydroxyacyl-CoA dehydrogenase (ECoAH/I/
HACoADH) was found in the group (iii) glycosomal proteins.
Glycosomes (like many peroxisomes) are also known for ether
lipid synthesis,4,36 and dihydroxyacetone-3-phosphate acyltran-
sterase (DHAPAT) and alkyl-dihydroxyacetone-3-phosphate
synthase (DHPS) were both found. Finally, the presqualene
segement of isoprenoid/sterol synthesis has been described in
mammalian peroxisomes37 and suggested to be glycosomal
based on the presence of PTS sequences on some of the
components.5 Here we ﬁnd two enzymes on the pathway from
mevalonate to squalene, mevalonate kinase (MK) and
isopentyl-diphosphate delta isomerase (IPDI), as well as
some other postsqualene enzymes of sterol biosynthesis.
Figure 4. Plot of the combined glycosome proteomics data. Each
protein identiﬁcation is represented by a point plotted as the Log2 of
their heavy-to-light isotope ratio (x axis) versus the Log10 value of the
combined intensities of the peptides belonging to each protein (y axis).
The black and blue curves represent three and eight standard
deviations (sd) from the mean. (See the Experimental Procedures.)
Proteins plotted in red within the three sd curves are designated group
(i) (contaminants), those plotted in amber between the 3 and 8 sd
curves are group (ii), and those beyond the 8 sd curves are designated
group (iii).
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Group (ii) Proteins Include Glycosomal and Endoplasmic
Reticulum Components
There are several proteins in group (ii) that are known to
belong to the ER, for example, components of the protein N-
glycosylation, ER quality control, and GPI anchor addition
machineries. It is likely that Pex13.1, like many peroxisomal
membrane proteins, is made in the ER,36,38 and that, therefore,
using a GFP-Pex13.1 fusion protein as bait for the pull-out
experiments will not only enrich glycosomal proteins but also
some ER proteins that are physically close to GFP-Pex13.1 the
moment of cell lysis. Discriminating bone ﬁde glycosomal
proteins from ER proteins in group (ii) is therefore complex.
The prevailing model of peroxisome biogenesis is that they
multiply by growing and budding. While the newly budded
organelles directly take up matrix proteins and some membrane
proteins (via the PEX19/PEX16 pathway) they also fuse with
ER-derived vesicles that provide membrane lipids and other
membrane proteins.38 On the basis of this, we performed a
label and chase experiment, whereby we heavy-labeled
trypanosome proteins to steady-state with R6K4, inducing the
expression of GFP-Pex13.1 for the last 16 h of that labeling and
then chased that label by incubating the cells in light medium
containing R0Ko for 5 h. We then enriched for glycosomes
using anti-GFP beads and performed quantitative proteomics,
as before. As expected, most peptides, especially those from the
group (iii) proteins, showed a signiﬁcant reduction in their
heavy/light ratios (by about 1 log2 unit; Table S4 in the
Supporting Information). However, the group (ii) proteins
could now be separated into subgroups: 50 with decreasing
heavy/light ratios, which we suggest are ER proteins that were
simply in the vicinity GFP-Pex13.1 the moment of cell rupture;
29 with increasing heavy/light ratios, which we suggest are
bone ﬁde ER-derived glycosomal proteins that, for whatever
reason, take longer to reach the mature glycosomes than the
group (iii) proteins; and 42 with relatively unchanged heavy/
light ratios, which we would not like to call either way. Finally,
there are an additional 56 group (ii) proteins in Table S2 in the
Supporting Information that were not featured in this particular
experiment. This brings our list of high-conﬁdence glycosomal
proteins to 158 (indicated in green in the glycosome status
column; Table S2 in the Supporting Information), with a
further 98 (i.e., 42 + 56) in the “possible” category (indicated
by gray and white, respectively, in the glycosome status column;
Table S2 in the Supporting Information) and 50 excluded
(indicated in red in the glycosome status column; Table S2 in
the Supporting Information). Some of the group (ii) proteins
elevated to the status of high-conﬁdence glycosomal proteins
by this chase experiment include: Pex6, part of the peroxisome
biosynthetic machinery; monoglyceride lipase (MGL) and acyl-
CoA binding protein (ACBP), which most likely play a role in
beta-oxidation by generating free fatty acid and chaperoning
acyl-CoA molecules, respectively; glyoxylase II (GLXII), which
presumably plays a role in the redox system, returning
trypanothione thioesters to free trypanothione;39 the enzyme
UDP-glucose 4′-epimerase (GALE), part of sugar nucleotide
metabolism and previously shown to be glycosomal;8 and the
CAAX protease, a membrane protein that is part of the protein
prenylation system,40 presumably with its active site facing the
cytosol. Other components, discussed further later, are
associated with post-translational modiﬁcation and protein
folding, such as a heat-shock protein (HSP70), a protein
phosphatase 2C (PP2C-2), a protein kinase A catalytic subunit
(PKA) as well as a ‘nucleotide phosphate linked to X hydrolase’
(NUDIX-2),41 and a methyltransferase of unknown function
(drevMT).
Implications of the High-Conﬁdence Glycosome Proteome
for Known and Suggested Aspects Glycosome Metabolism
Many of the well-annotated proteins identiﬁed in our analysis
are indicated in Figure 5A,B with those belonging to group (i)
“non-glycosomal” in red, those belonging to the “possibly
glycosomal” category from group (ii) in amber, and those
belonging to group (iii) plus the elevated group (ii) proteins
belonging to “the high-conﬁdence glycosome proteome” in
green. Proteins that are expected to be glycosomal but that
were either not detected or for which the Log2(H/L) ratio
variance was too great are indicated in gray. All proteins that, so
far as we are aware, have not been previously described to be
glycosomal, are boxed. A list of the enzymes and their
abbreviations shown in Figure 5A,B is provided in Table S3 in
the Supporting Information.
While the group (iii) and elevated group (ii) proteins are
highly consistent with the known or suggested functions of T.
brucei glycosomes, a signiﬁcant number of the enzymes of the
pentose phosphate pathway, generally considered to be both
cytosolic and glycosomal,42 are missing. Thus, whereas glucose-
6-phosphate dehydrogenase (G6PDH) and 6-phosphogluco-
nolactonase (6PGL) are clearly present, as previously
reported,43,44 along with sedheptulose 1,7-bisphosphatase
(SBP),42 others (enzymes in gray) were either not detected,
like ribulose 5-phosphate isomerase (R5I), or statistically
excluded due to high variance between replicates, like
transketolase (TK). Furthermore, some pentose phosphate
pathway enzymes were identiﬁed in group (i), suggesting they
are contaminants rather than bone ﬁde glycosome components
(enzymes in red). These include transaldolase (TA), ribulose 5-
phosphate epimerase (R5E) and 6-phosphogluconate dehydro-
genase (6PGDH). While these data do not formally exclude the
presence of a complete pentose phosphate pathway in procyclic
form glycosomes, they suggest that direct experimental
localization studies are perhaps warranted before this is taken
for granted. Indeed, the majority of transketolase has been
previously reported to be in the cytosol.45
With respect to the glycolytic pathway downstream of
glycerate 1,3 bisphosphate (1,3BPGA), phosphoenolpyruvate
carboxykinase (PEPCK), malate dehydrogenase (MD), and
NADH-dependent fumarate reductase (FR) are all clearly
present in the group (iii) proteins, but fumarate hydratase (FH)
is, like enolase (ENO) and malic enzyme (ME), a group (i)
protein, suggesting that all are located without the glycosome.
This may be signiﬁcant because the presence of FH in the
glycosomes as well as in the cytosol has been previously
suggested.46 The absence of FH in the glycosomes would mean
that the transmembrane transport of malate and fumarate
would be essential for the production of glycosomal succinate,
required for NAD+/NADH balance inside the procyclic
glycosome.
Interestingly, in addition to the ABC transporter GAT1 that
transports oleoyl-CoA into the glycosome,47 a putative
carnitine O-acyltransferase (ACT) was also found, suggesting
that there may be an acyl carnitine translocase/carnitine O-
acyltransferase shuttle to bring acyl-carnitines into the
glycosome and convert them to acyl-CoA species as substrates
for beta-oxidation and other processes like ether lipid synthesis.
Other possible sources of acyl-CoA substrates are the
phospholipase A1 (PLA1), lyso-phospholipase (lysoPL), and
Journal of Proteome Research Article
dx.doi.org/10.1021/pr401209w | J. Proteome Res. 2014, 13, 2796−28062802
monoglyceride lipase (MGL) enzymes that could provide free
fatty acids to the acyl-CoA synthase (ACS). In addition, a
putative thioesterase could be involved in regulating the
intraglycosomal acyl-CoA to free fatty acid balance.48
Novel Glycosomal Functions Suggested by the
High-Conﬁdence Glycosome Proteome
Several of the enzymes in the 158 conﬁdently assigned
glycosomal proteins list do not obviously or directly fall into
conventional glycosomal metabolic pathways, and these are
mostly shown in Figure 5B. The presence of NUDIX enzymes
in the glycosome (in the case of Tb927.5.4350, consistent with
having a PTS2 signal sequence and with one of the Colasante
proteomes17) probably makes sense with respect to the
relatively high concentrations of nucleotides, sugar nucleotides,
(acyl-)CoA, and NAD(H), which will be present in the
organelle. Thus, NUDIX hydrolases can help to destroy
nucleotides damaged by reactive oxygen species,41 and
mammalian and yeast peroxisomal NUDIX proteins have
been shown to act as CoA and acyl-CoA diphosphatases,
preventing the buildup of CoA cofactors.48 Similarly, the
presence of some protein quality control/folding machinery in
such a metabolically active compartment (i.e., HSP40, HSP70,
and peptidyl-prolyl isomerase (PPI)) is, in retrospect, not
particularly surprising. Perhaps the most unexpected glyco-
somal components are members of protein phosphatase
families, which include serine/threonine phosphatases and a
pseudotyrosine phosphatase.49 By cross-referencing our glyco-
somal proteome and phosphoproteome data,31 we see that
although the glycosomes contain several phosphoproteins and
protein phosphatases (Table S2 in the Supporting Informa-
tion), they do not contain detectable protein kinases other than
PKA, which together with its putative neurobeachin membrane
anchoring protein50 most likely faces the outside of the
organelle. This suggests that information (e.g., relating to
metabolic or cell-cycle status) might be transmitted from the
cytosol to the glycosome to exert metabolic control through the
import of phosphorylated cargo and that this “information”
might naturally decay once in the glycosome through
dephosphorylation. This is consistent with some of the
hypotheses of Matthews and colleagues.51 Furthermore, one
might speculate that the glycosomal catalytically inactive
tyrosine phosphatase could be present to “read” the tyrosine
phosphorylation status of imported phosphoproteins. Some of
the phosphorylated glycosomal proteins include enzymes of
carbohydrate metabolism, such as phosphofructokinase (PFK),
triosephosphate isomerase (TPI), aldolase (ALD), PEPCK, FR,
HK, PGK, and GK, as well as redox and other components.
Many of the phosphorylation site occupancies vary consid-
erably between bloodstream form and procyclic form
trypanosomes for these enzymes and other glycosomal
components (Table S2 in the Supporting Information);31
however, whether phosphorylation modulates any of these
activities remains to be determined.
Figure 5. Glycosome metabolism and function according to the
glycosome proteome data reported in this paper. The blue lines
indicate the glycosome membrane, and the blue arrows indicate
transmembrane transport of metabolites. (A) Areas of known or
suggested glycosomal metabolism and (B) the glycosomal protein
import machinery (Pex proteins) and areas of glycosomal metabolism
that have not been previously described. Metabolites are in black. The
enzyme abbreviations are in italics and appear in boxes if they have not
been previously demonstrated or suggested to be glycosomal. The key
to their full names appears in Table S3 in the Supporting Information,
and the numbers 1 and 2 in brackets following the enzyme
abbreviations indicate the presence of PTS1 and PTS2 targeting
sequences. Enzyme and protein abbreviations appear green if they
belong to the “high-conﬁdence glycosome proteome”, amber if they
Figure 5. continued
belong to the “possibly glycosomal protein’ category, red if their
SILAC ratios suggest they are without the glycosome, and gray if they
were either not detected or if data variance was too great to assign
location.
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■ DISCUSSION
Glycosome proteomes have been previously published using
density gradient centrifugation enrichment prior to proteomic
analyses.17−19 While the organelle enrichment in these studies
may be superior to that described here by epitope-tagging and
magnetic bead pull-out, only the latter is compatible with
SILAC methodology, summarized in Figure 1, which greatly
assists the discrimination of genuine components from
contaminants. The analysis by Vertommen et al.19 preselected
known and suggested glycosome proteins from the data sets
and made semiquantitative comparisons, by spectral counting,
between the bloodstream and procyclic forms of the parasite.
This successfully highlighted metabolic changes between the
two lifecycle stages but did not claim to automatically
distinguish glycosomal from nonglycosomal proteins. The
Colasante et al. studies17,18 also fully acknowledged the
limitations of glycosome enrichment alone to unambiguously
identify the glycosome proteome because contamination from
other compartments, particularly the mitochondrion, is
inevitable. This becomes apparent if their protein identiﬁcations
are superimposed on our SILAC data set, when the extent of
group (i) (likely contaminant) protein identiﬁcations in these
proteomes becomes evident (Figure 6A,B).
A convenient way to predict potential glycosomal proteins is
to search for peroxisome targeting sequences (PTS) in the
predicted amino acid sequences of trypanosome ORFs.5 This
approach recognizes that false positive and negative assign-
ments are made in searching for C-terminal PTS1 and N-
terminal PTS2 sequences, and the extent of the problem is
evident when proteins containing one or both of these signals is
superimposed on our data set (Figure 6C). Overall, 60 PTS-
containing proteins were found in the 158 proteins of the high-
conﬁdence glycosome proteome, and 77 were found among the
group (i) protein contaminants, suggesting that use of PTS
signal sequence search in T. brucei, while useful, has a sensitivity
of <40% and a speciﬁcity of <50%.
Finally, we, and others,19,52 are interested in glycosome
membrane proteins that might be involved in metabolite
transport into and out of these organelles. Proteins containing
one or more predicted transmembrane domains are well
distributed across all three protein groups, as indicated in
Figure 6D. Of the 35 transmembrane proteins in the high-
conﬁdence glycosome proteome, 13 are of known glycosome
location, such as eight of the Pex proteins (Pex2, 10, 11, 12,
13.1, 13.2, 14, 22), the Pex11-related proteins Gim5A and
Gim5B,53 and the glycosome ABC transporters (GAT1, 2, and
3).54 The others are mostly hypothetical proteins of unknown
function. It is worth noting that GAT2 was previously thought
to be bloodstream form speciﬁc.47,54
In summary, we have used organelle epitope tagging,
magnetic bead enrichment, and SILAC proteomics to obtain
a high-conﬁdence procyclic form T. brucei glycosome proteome
of 158 proteins with a further 98 proteins in a possibly
glycosomal category. These data should be a useful resource for
the trypanosome biology community.
Figure 6. Correlation of the combined glycosome proteomic data in this study with other experimental and theoretical data. The plots are the same
as that shown in Figure 4, except that only the three sd limit is shown (black curves) and all data points are plotted in gray unless they appear in the
following data sets: (A) Red points indicate those proteins identiﬁed in the total glycosome proteome of Colasante et al. (2006).17 (B) Red points
indicate those proteins identiﬁed in the total glycosome proteome of Colasante et al. (2013).18 (C) Light blue points indicate those proteins
containing a PTS1 signal peptide, black points indicate those proteins containing a PTS2 signal peptide, and red points indicate those proteins
containing a PTS1 and PTS2 signal peptide. (D) Red points indicate those proteins predicted to contain one transmembrane domain and blue
points indicate those proteins predicted to contain more than one transmembrane domain.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr401209w | J. Proteome Res. 2014, 13, 2796−28062804
■ ASSOCIATED CONTENT
*S Supporting Information
Figure S1. SDS-PAGE of glycosome preparations used for
proteomics. Figure S2. Correlation of biological replicate
experiments. Table S1. MaxQuant output data from the
combined biological and technical replicates described in
Table 1. Information on the presence of PTS1 and PTS2
sequences, transmembrane domains, and occurrence in the data
sets of Colasante et al.17,18 are included. Table S2. Summary of
protein identiﬁcations, indicating under glycosome status
(column F), the high-conﬁdence glycosome proteome
(green), the “possibly glycosomal” group (white and gray),
and the contaminants (red), and phosphorylation site data
(columns I and J) taken from Urbaniak et al. (2013)31 and
annotated and predicted subcelluar localization information
taken from the GO terms in TritrypDB29 (columns K and L).
Table S3. Enzymes identiﬁed in the high-conﬁdence glycosome
proteome (green in Column C) and in the “possibly
glycosomal” group (amber in Column C), together with their
abbreviations (Column A). Table S4. Classiﬁcation of group
(ii) proteins into glycosomal (green), “possibly glycosomal”
(gray) or nonglycosomal contaminants (red) using the label-
chase data. The mass spectrometry proteomics data have been
deposited to the ProteomeXchange Consortium (http://
proteomecentral.proteomexchange.org) via the PRIDE partner
repository55 with the data set identiﬁer PXD000663. This
material is available free of charge via the Internet at http://
pubs.acs.org.
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: m.a.j.ferguson@dundee.ac.uk. Tel: 44-1382-384219.
Fax: 44-1382-388535.
Present Address
§M.D.U.: Division of Biomedical and Life Sciences, Lancaster
University, Lancaster LA1 4YG, U.K.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Douglas Lamont and Kenny Beattie for expert
assistance with LC−MS/MS, John James and Martin Kierans
for expert assistance with electron microscopy, Paul Michels for
antibodies, constructs, and helpful discussions, and Christine
Clayton for the anti-Pex11 antibody. This work was supported
by a Programme Grant (085622) and a Senior Investigator
Award (101842) to M.A.J.F. from the Wellcome Trust. The
necessary proteomics, microscopy, and computing infra-
structure were supported by Wellcome Trust Strategic Awards
(097945 and 100476).
■ ABBREVIATIONS
FASP, ﬁlter aided sample preparation; Pex, peroxin; PTS,
peroxisome targeting sequence; SILAC, stable isotope labeling
by amino acids in cell culture; T. brucei, Trypanosoma brucei
■ REFERENCES
(1) Gabaldon, T. Peroxisome diversity and evolution. Philos. Trans. R.
Soc., B 2010, 365, 765−773.
(2) Opperdoes, F. R. Localization of the initial steps in
alkoxyphospholipid biosynthesis in glycosomes (microbodies) of
Trypanosoma brucei. FEBS Lett. 1984, 169, 35−39.
(3) Gualdron-Lopez, M.; Brennand, A.; Hannaert, V.; Quinones, W.;
Caceres, A. J.; Bringaud, F.; Concepcion, J. L.; Michels, P. A. When,
how and why glycolysis became compartmentalised in the
Kinetoplastea. A new look at an ancient organelle. Int. J. Parasitol.
2012, 42, 1−20.
(4) Zomer, A. W.; Opperdoes, F. R.; van den Bosch, H. Alkyl
dihydroxyacetone phosphate synthase in glycosomes of Trypanosoma
brucei. Biochim. Biophys. Acta 1995, 1257, 167−173.
(5) Opperdoes, F. R.; Szikora, J. P. In silico prediction of the
glycosomal enzymes of Leishmania major and trypanosomes. Mol.
Biochem. Parasitol. 2006, 147, 193−206.
(6) Parsons, M. Glycosomes: parasites and the divergence of
peroxisomal purpose. Mol. Microbiol. 2004, 53, 717−724.
(7) Michels, P. A.; Bringaud, F.; Herman, M.; Hannaert, V. Metabolic
functions of glycosomes in trypanosomatids. Biochim. Biophys. Acta
2006, 1763, 1463−1477.
(8) Roper, J. R.; Guther, M. L.; Macrae, J. I.; Prescott, A. R.;
Hallyburton, I.; Acosta-Serrano, A.; Ferguson, M. A. The suppression
of galactose metabolism in procylic form Trypanosoma brucei causes
cessation of cell growth and alters procyclin glycoprotein structure and
copy number. J. Biol. Chem. 2005, 280, 19728−19736.
(9) Turnock, D. C.; Izquierdo, L.; Ferguson, M. A. The de novo
synthesis of GDP-fucose is essential for flagellar adhesion and cell
growth in Trypanosoma brucei. J. Biol. Chem. 2007, 282, 28853−
28863.
(10) Stokes, M. J.; Guther, M. L.; Turnock, D. C.; Prescott, A. R.;
Martin, K. L.; Alphey, M. S.; Ferguson, M. A. The synthesis of UDP-
N-acetylglucosamine is essential for bloodstream form trypanosoma
brucei in vitro and in vivo and UDP-N-acetylglucosamine starvation
reveals a hierarchy in parasite protein glycosylation. J. Biol. Chem.
2008, 283, 16147−16161.
(11) Marino, K.; Guther, M. L.; Wernimont, A. K.; Amani, M.; Hui,
R.; Ferguson, M. A. Identification, subcellular localization, biochemical
properties, and high-resolution crystal structure of Trypanosoma
brucei UDP-glucose pyrophosphorylase. Glycobiology 2010, 20, 1619−
1630.
(12) Marino, K.; Guther, M. L.; Wernimont, A. K.; Qiu, W.; Hui, R.;
Ferguson, M. A. Characterization, localization, essentiality, and high-
resolution crystal structure of glucosamine 6-phosphate N-acetyl-
transferase from Trypanosoma brucei. Eukaryotic Cell 2011, 10, 985−
997.
(13) Bandini, G.; Marino, K.; Guther, M. L.; Wernimont, A. K.;
Kuettel, S.; Qiu, W.; Afzal, S.; Kelner, A.; Hui, R.; Ferguson, M. A.
Phosphoglucomutase is absent in Trypanosoma brucei and redun-
dantly substituted by phosphomannomutase and phospho-N-acetyl-
glucosamine mutase. Mol. Microbiol. 2012, 85, 513−534.
(14) Kuettel, S.; Wadum, M. C.; Guther, M. L.; Marino, K.; Riemer,
C.; Ferguson, M. A. The de novo and salvage pathways of GDP-
mannose biosynthesis are both sufficient for the growth of
bloodstream-form Trypanosoma brucei. Mol. Microbiol. 2012, 84,
340−351.
(15) Moyersoen, J.; Choe, J.; Fan, E.; Hol, W. G.; Michels, P. A.
Biogenesis of peroxisomes and glycosomes: trypanosomatid glyco-
some assembly is a promising new drug target. FEMS Microbiol. Rev.
2004, 28, 603−643.
(16) Gualdron-Lopez, M.; Brennand, A.; Avilan, L.; Michels, P. A.
Translocation of solutes and proteins across the glycosomal membrane
of trypanosomes; possibilities and limitations for targeting with
trypanocidal drugs. Parasitology 2013, 140, 1−20.
(17) Colasante, C.; Ellis, M.; Ruppert, T.; Voncken, F. Comparative
proteomics of glycosomes from bloodstream form and procyclic
culture form Trypanosoma brucei brucei. Proteomics 2006, 6, 3275−
3293.
(18) Colasante, C.; Voncken, F.; Manful, T.; Ruppert, T.; Tielens, A.
G. M.; van Hellemond, J. J.; Clayton, C. Proteins and lipids of
Journal of Proteome Research Article
dx.doi.org/10.1021/pr401209w | J. Proteome Res. 2014, 13, 2796−28062805
glycosmal membranes from Leishmania tarentole and Trypanosoma
brucei. F1000Research 2013, 2, 27.
(19) Vertommen, D.; Van Roy, J.; Szikora, J. P.; Rider, M. H.;
Michels, P. A.; Opperdoes, F. R. Differential expression of glycosomal
and mitochondrial proteins in the two major life-cycle stages of
Trypanosoma brucei. Mol. Biochem. Parasitol. 2008, 158, 189−201.
(20) Wirtz, E.; Leal, S.; Ochatt, C.; Cross, G. A. A tightly regulated
inducible expression system for conditional gene knock-outs and
dominant-negative genetics in Trypanosoma brucei. Mol. Biochem.
Parasitol. 1999, 99, 89−101.
(21) Brun, R.; Schonenberger. Cultivation and in vitro cloning or
procyclic culture forms of Trypanosoma brucei in a semi-defined
medium. Short communication. Acta Trop. 1979, 36, 289−292.
(22) Brennand, A.; Rigden, D. J.; Michels, P. A. Trypanosomes
contain two highly different isoforms of peroxin PEX13 involved in
glycosome biogenesis. FEBS Lett. 2012, 586, 1765−1771.
(23) Guther, M. L.; Lee, S.; Tetley, L.; Acosta-Serrano, A.; Ferguson,
M. A. GPI-anchored proteins and free GPI glycolipids of procyclic
form Trypanosoma brucei are nonessential for growth, are required for
colonization of the tsetse fly, and are not the only components of the
surface coat. Mol. Biol. Cell 2006, 17, 5265−5274.
(24) Urbaniak, M. D.; Guther, M. L.; Ferguson, M. A. Comparative
SILAC proteomic analysis of Trypanosoma brucei bloodstream and
procyclic lifecycle stages. PLoS One 2012, 7, e36619.
(25) Opperdoes, F. R.; Baudhuin, P.; Coppens, I.; De Roe, C.;
Edwards, S. W.; Weijers, P. J.; Misset, O. Purification, morphometric
analysis, and characterization of the glycosomes (microbodies) of the
protozoan hemoflagellate Trypanosoma brucei. J. Cell Biol. 1984, 98,
1178−1184.
(26) Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M.
Universal sample preparation method for proteome analysis. Nat.
Methods 2009, 6, 359−362.
(27) Cox, J.; Mann, M. MaxQuant enables high peptide identification
rates, individualised p.p.b.-range mass accuracies and proteome-wide
protein quantification. Nat. Biotechnol. 2008, 26, 1367−1372.
(28) Cox, J.; Neuhausert, N.; Michalskit, A.; Scheltemat, R. A.; Olsen,
J. V.; Mann, M. Andromeda: a peptide search engine integrated into
the MaxQuant environment. J. Proteome Res. 2011, 10, 1794−1805.
(29) Aslett.; et al. TriTrypDB: a functional genomic resource for the
Trypanosomatidae. Nucleic Acid Res. 2010, 38, D457−D462.
(30) Quackenbush, J. Microarray data normalization and trans-
formation. Nat. Genet. 2002, 32 (Suppl), 496−501.
(31) Urbaniak, M. D.; Martin, D. M.; Ferguson, M. A. Global
quantitative SILAC phosphoproteomics reveals differential phosphor-
ylation is widespread between the procyclic and bloodstream form
lifecycle stages of Trypanosoma brucei. J. Proteome Res. 2013, 12,
2233−2244.
(32) Urbaniak, M. D.; Turnock, D. C.; Ferguson, M. A. Galactose
starvation in a bloodstream form Trypanosoma brucei UDP-glucose
4′-epimerase conditional null mutant. Eukaryotic Cell 2006, 5, 1906−
1913.
(33) Voncken, F.; van Hellemond, J. J.; Pfisterer, I.; Maier, A.;
Hillmer, S.; Clayton, C. Depletion of GIM5 causes cellular fragility, a
decreased glycosome number, and reduced levels of ether-linked
phospholipids in trypanosomes. J. Biol. Chem. 2003, 278, 35299−
35310.
(34) Krogh, A.; Larsson, B.; von Heijne, G.; Sonnhammer, E. L.
Predicting transmembrane protein topology with a hidden Markov
model: application to complete genomes. J. Mol. Biol. 2001, 305, 567−
580.
(35) Wilkinson, S. R.; Prathalingam, S. R.; Taylor, M. C.; Horn, D.;
Kelly, J. M. Vitamin C biosynthesis in trypanosomes: a role for the
glycosome. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 11645−11650.
(36) Michels, P. A.; Moyersoen, J.; Krazy, H.; Galland, N.; Herman,
M.; Hannaert, V. Peroxisomes, glyoxysomes and glycosomes (review).
Mol. Membr. Biol. 2005, 22, 133−145.
(37) Kovacs, W. J.; Tape, K. N.; Shackelford, J. E.; Duan, X.;
Kasumov, T.; Kelleher, J. K.; Brunengraber, H.; Krisans, S. K.
Localization of the pre-squalene segment of the isoprenoid
biosynthetic pathway in mammalian peroxisomes. Histochem. Cell
Biol. 2007, 127, 273−290.
(38) Nuttall, J. M.; Motley, A.; Hettema, E. H. Peroxisome
biogenesis: recent advances. Curr. Opin Cell Biol. 2011, 23, 421−426.
(39) Wendler, A.; Irsch, T.; Rabbani, N.; Thornalley, P. J.; Krauth-
Siegel, R. L. Glyoxalase II does not support methylglyoxal
detoxification but serves as a general trypanothione thioesterase in
African trypanosomes. Mol. Biochem. Parasitol. 2009, 163, 19−27.
(40) Gillespie, J. R.; Yokoyama, K.; Lu, K.; Eastman, R. T.; Bollinger,
J. G.; Van Voorhis, W. C.; Gelb, M. H.; Buckner, F. S. C-terminal
proteolysis of prenylated proteins in trypanosomatids and RNA
interference of enzymes required for the post-translational processing
pathway of farnesylated proteins. Mol. Biochem. Parasitol. 2007, 153,
115−124.
(41) McLennan, A. G. The Nudix hydrolase superfamily. Cell. Mol.
Life Sci. 2006, 63, 123−143.
(42) Hannaert, V.; Bringaud, F.; Opperdoes, F. R.; Michels, P. A.
Evolution of energy metabolism and its compartmentation in
Kinetoplastida. Kinetoplastid. Biol. Dis. 2003, 2, 11.
(43) Heise, N.; Opperdoes, F. R. Purification, localisation and
characterisation of glucose-6-phosphate dehydrogenase of Trypanoso-
ma brucei. Mol. Biochem. Parasitol. 1999, 99, 21−32.
(44) Duffieux, F.; Van Roy, J.; Michels, P. A.; Opperdoes, F. R.
Molecular characterization of the first two enzymes of the pentose-
phosphate pathway of Trypanosoma brucei. Glucose-6-phosphate
dehydrogenase and 6-phosphogluconolactonase. J. Biol. Chem. 2000,
275, 27559−27565.
(45) Stoffel, S. A.; Alibu, V. P.; Hubert, J.; Ebikeme, C.; Portais, J. C.;
Bringaud, F.; Schweingruber, M. E.; Barrett, M. P. Transketolase in
Trypanosoma brucei. Mol. Biochem. Parasitol. 2011, 179, 1−7.
(46) Bringaud, F.; Riviere, L.; Coustou, V. Energy metabolism of
trypanosomatids: adaptation to available carbon sources. Mol. Biochem.
Parasitol. 2006, 149, 1−9.
(47) Igoillo-Esteve, M.; Mazet, M.; Deumer, G.; Wallemacq, P.;
Michels, P. A. Glycosomal ABC transporters of Trypanosoma brucei:
characterisation of their expression, topology and substrate specificity.
Int. J. Parasitol. 2011, 41, 429−438.
(48) Antonenkov, V. D.; Hiltunen, J. K. Transfer of metabolites
across the peroxisomal membrane. Biochim. Biophys. Acta 2012, 1822,
1374−1386.
(49) Brenchley, R.; Tariq, H.; McElhinney, H.; Szoor, B.; Huxley-
Jones, J.; Stevens, R.; Matthews, K.; Tabernero, L. The TriTryp
phosphatome: analysis of the protein phosphatase catalytic domains.
BMC Genomics 2007, 8, 434.
(50) Wang, X.; Herberg, F. W.; Laue, M. M.; Wullner, C.; Hu, B.;
Petrasch-Parwez, E.; Kilimann, M. W. Neurobeachin: A protein kinase
A-anchoring, beige/Chediak-higashi protein homolog implicated in
neuronal membrane traffic. J. Neurosci. 2000, 20, 8551−8565.
(51) Szoor, B.; Ruberto, I.; Burchmore, R.; Matthews, K. R. A novel
phosphatase cascade regulates differentiation in Trypanosoma brucei
via a glycosomal signaling pathway. Genes Dev. 2010, 24, 1306−1316.
(52) Gualdron-Lopez, M.; Vapola, M. H.; Miinalainen, I. J.; Hiltunen,
J. K.; Michels, P. A.; Antonenkov, V. D. Channel-forming activities in
the glycosomal fraction from the bloodstream form of Trypanosoma
brucei. PLoS One 2012b, 7, e34530.
(53) Voncken, F.; van Hellemond, J. J.; Pfisterer, I.; Maier, A.;
Hillmer, S.; Clayton, C. Depletion of GIM5 causes cellular fragility, a
decreased glycosome number, and reduced levels of ether-linked
phospholipids in trypanosomes. J. Biol. Chem. 2003, 278, 35299−
35310.
(54) Yernaux, C.; Fransen, M.; Brees, C.; Lorenzen, S.; Michels, P. A.
Trypanosoma brucei glycosomal ABC transporters: identification and
membrane targeting. Mol. Membr. Biol. 2006, 23, 157−172.
(55) Vizcaino, J. A.; Cote, R.; Csordas, A.; Dianes, J. A.; Fabregat, A.;
Foster, J. M.; Griss, J.; Alpi, E.; Biri, M.; Contell, J.; O’Kelly, G.;
Schoenegger, A.; Ovelleiro, D.; Perez-Riverol, Y.; Reisinger, F.; Rios,
D.; Wang, R.; Hermjakob, H. The PRoteomics IDEntifications
(PRIDE) database and associated tools: status in 2013. Nucleic Acids
Res. 2013, 41, D1063−1069.
Journal of Proteome Research Article
dx.doi.org/10.1021/pr401209w | J. Proteome Res. 2014, 13, 2796−28062806
